STK39 and breast carcinoma: Considering that epigenetic silencing like methylation has been reported to be one of the most effective processes for the regulation of STK39 expression, it is reasonable to speculate that such probe targeting STK39 may also distinguish luminal subtypes from other breast cancer subtypes [85].